JFS Wealth Advisors’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
CIP
FAM
FLAM
JFS Wealth Advisors's ATRC Position: Q1 2023 in Review
JFS Wealth Advisors sold out of AtriCure (ATRC) in Q1 2023, closing a stake of 9 shares — an estimated $399 sold.
JFS Wealth Advisors first reported a position in ATRC in Q1 2022 and held it in 4 quarters. The position peaked at $1K in Q1 2022. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2023.
- JFS Wealth Advisors reported no remaining AtriCure position as of Q1 2023 after selling out during the quarter.
- JFS Wealth Advisors sold 9 AtriCure shares in Q1 2023, an estimated $399.
- JFS Wealth Advisors first reported a position in AtriCure in Q1 2022 and held it in 4 quarters.
- JFS Wealth Advisors's AtriCure position peaked at $1K in Q1 2022.
- 224 funds tracked by Wall St. Rank held AtriCure as of Q1 2023.
Based on JFS Wealth Advisors's 13F filing for Q1 2023, filed 19 Apr 2023.